ATYPICAL NEUROFIBROMA
Clinical trials for ATYPICAL NEUROFIBROMA explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL NEUROFIBROMA trials appear
Sign up with your email to follow new studies for ATYPICAL NEUROFIBROMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a pill shrink nerve tumors in NF1? new trial aims to find out
Disease control Recruiting nowThis study tests the drug abemaciclib, typically used for cancer, in people with neurofibromatosis type 1 (NF1) who have atypical neurofibromas that cannot be surgically removed. The goal is to find a safe dose and see if it can shrink or stabilize these tumors. Participants take…
Matched conditions: ATYPICAL NEUROFIBROMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a Two-Drug combo stop nerve tumors from turning cancerous?
Disease control Recruiting nowThis trial is testing whether combining two drugs—selumetinib and APG-115—can help people with neurofibromatosis type 1 (NF1) who have nerve sheath tumors that are either pre-cancerous or already cancerous. The study aims to find a safe dose and see if the combination can shrink …
Matched conditions: ATYPICAL NEUROFIBROMA
Phase: PHASE1, PHASE2 • Sponsor: AeRang Kim • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC